drugset / Trial / NCT00223041
Cranoc Lipid Study in Renal Transplantation
RandomizedParallel-groupOpen-labelPrevention
Summary
Cardiovascular disease after renal transplantation is an important problem. Patients after renal transplantation with low LDL-Levels (\<130mg/dl) receive Fluvastatin 80mg/day (or no medication, to look for the cardiovascular outcome with and without statins.
Timeline
- Start
- 2003-04
- Primary completion
- 2009-11
- Completion
- 2010-12
Outcome
Outcome not reported
Stopped: “No possibilty to receive all plened patients for this study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluvastatin | Other / unclassified | 80 mg | — |
Indications
No indication recorded.